Sitagliptin Glenmark 50 mg Norge - norsk - Statens legemiddelverk

sitagliptin glenmark 50 mg

glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg

Sitagliptin Glenmark 25 mg Norge - norsk - Statens legemiddelverk

sitagliptin glenmark 25 mg

glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg

Sitagliptin Glenmark 100 mg Norge - norsk - Statens legemiddelverk

sitagliptin glenmark 100 mg

glenmark arzneimittel gmbh - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg

Sitagliptin Hexal 50 mg Norge - norsk - Statens legemiddelverk

sitagliptin hexal 50 mg

hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg

Sitagliptin Hexal 25 mg Norge - norsk - Statens legemiddelverk

sitagliptin hexal 25 mg

hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg

Sitagliptin Hexal 100 mg Norge - norsk - Statens legemiddelverk

sitagliptin hexal 100 mg

hexal a/s - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 100 mg

Teriflunomide Mylan Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide mylan

mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).

Teriflunomide Accord Den europeiske union - norsk - EMA (European Medicines Agency)

teriflunomide accord

accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).

Sitagliptin Sandoz 25 mg Norge - norsk - Statens legemiddelverk

sitagliptin sandoz 25 mg

sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 25 mg

Sitagliptin Sandoz 50 mg Norge - norsk - Statens legemiddelverk

sitagliptin sandoz 50 mg

sandoz - københavn - sitagliptinhydrokloridmonohydrat - tablett, filmdrasjert - 50 mg